Home > Journals > Minerva Cardioangiologica > Past Issues > Minerva Cardioangiologica 2005 August;53(4) > Minerva Cardioangiologica 2005 August;53(4):287-98

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA CARDIOANGIOLOGICA

A Journal on Heart and Vascular Diseases


Official Journal of the Italian Society of Angiology and Vascular Pathology
Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,695


eTOC

 

REVIEWS  


Minerva Cardioangiologica 2005 August;53(4):287-98

Copyright © 2005 EDIZIONI MINERVA MEDICA

language: English

Surgical treatment of the failing heart

Singh R. R., Lisle T. C., Kron I. L.


PDF  


Heart failure is one of the leading causes of hospitalization worldwide. Currently, most therapeutic strategies are aimed at resolving the acute exacerbation of failure, resulting in a high readmission rate. Despite significant advances in the medical treatment of heart failure, the results are far from perfect. Mortality remains high and hospitalization costly. Surgi-cal management is still required for patients with end-stage heart failure. Unfortu-nately, its evolution has occurred in a less structured fashion. In addition to transplantation, strategies for the treatment of heart failure currently under investigation include implantation of pacemakers, left ventricular reconstruction, mitral valve repair, coronary revascularization, cardiomyoplasty and mechanical circulatory support. In the end however, the surgical management of patients with heart failure rests on the type of underlying cardiomyopathy. Hence, care must be taken to accurately diagnose these patients as either having dilated or ischemic cardiomyopathy.

top of page

Publication History

Cite this article as

Corresponding author e-mail